Ongoing Clinical Trials:

Dr. Anthony Mikulec

Meniere's Disease - A Prospective , Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase 1B Study of OTO-104 Given As A Single Intratympanic Injection In Subjects With Unilateral Meniere's Disease.

Call 314-577-8884 for more information